➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Boehringer Ingelheim
McKesson
Medtronic
Colorcon

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

DOPAMINE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Dopamine Hydrochloride patents expire, and when can generic versions of Dopamine Hydrochloride launch?

Dopamine Hydrochloride is a drug marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun. and is included in thirty-six NDAs.

The generic ingredient in DOPAMINE HYDROCHLORIDE is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dopamine Hydrochloride

A generic version of DOPAMINE HYDROCHLORIDE was approved as dopamine hydrochloride by HOSPIRA on February 4th, 1982.

  Try it Free

Summary for DOPAMINE HYDROCHLORIDE
Drug patent expirations by year for DOPAMINE HYDROCHLORIDE
Recent Clinical Trials for DOPAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stephen G. Kaler, MDPhase 1/Phase 2
Central South UniversityN/A
Cairo UniversityPhase 4

See all DOPAMINE HYDROCHLORIDE clinical trials

Pharmacology for DOPAMINE HYDROCHLORIDE
Drug ClassCatecholamine
Medical Subject Heading (MeSH) Categories for DOPAMINE HYDROCHLORIDE

US Patents and Regulatory Information for DOPAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 019099-003 Oct 15, 1986 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teligent DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 018656-001 Jun 28, 1983 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hospira DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 018826-003 Sep 30, 1983 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Baxter Hlthcare DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 019615-003 Mar 27, 1987 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Lyphomed DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 018549-001 Mar 11, 1983 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teva Parenteral DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 072999-001 Oct 23, 1991 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Smith And Nephew DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070011-001 Aug 29, 1985 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Boehringer Ingelheim
McKesson
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.